Skip to main content
SpringerLink
Log in

Screening and Surveillance

  • Chapter
Colorectal Cancer

Part of the book series: Current Clinical Oncology ((CCO))

  • 242 Accesses

Abstract

The cumulative lifetime risk of developing colorectal cancer for men and women in the United States is about 6% (1). In 2001, colorectal cancer is expected to be the fourth most common cause of cancer, accounting for over 135,000 new cases, and the second most common cause of cancer death, resulting in approx 57,000 deaths, among Americans (1). The detection of early-stage disease at diagnosis is associated with significantly improved survival, with a 5-yr survival rate of greater than 90% for those with localized disease (2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer Statistics, 2001. CA: Cancer J. Clin., 51 (2001) 15–36.

    Article  CAS  Google Scholar 

  2. Ries LAG, Kosary CL, Hankey BF, Miller BA, and Edwards BK (eds.). SEER Cancer Statistics, 1973–1995. National Cancer Institute, Bethesda, MD, 1998.

    Google Scholar 

  3. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N. Engl. J. Med., 329 (1993) 1977–1981.

    Article  PubMed  CAS  Google Scholar 

  4. Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology, 93 (1987) 1009–1013.

    PubMed  CAS  Google Scholar 

  5. Atkin WS, Morson BC, and Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N. Engl. J. Med., 326 (1992) 658–662.

    Article  PubMed  CAS  Google Scholar 

  6. Gloeckler-Ries LA, Hankey BF, and Edwards BK (eds.). Cancer Statistics Review, 1973–1987. Department of Health and Human Services, Bethesda, MD, DHHS publication no. (NIH) 90–2789, 1990.

    Google Scholar 

  7. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med., 328 (1993) 1365–1371.

    Article  PubMed  CAS  Google Scholar 

  8. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472–1477.

    Google Scholar 

  9. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet, 348 (1996) 1467–1471.

    Article  PubMed  CAS  Google Scholar 

  10. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J. Natl. Cancer Inst., 85 (1993) 1311–1318.

    Article  PubMed  CAS  Google Scholar 

  11. Selby JV, Friedman GD, Quesenberry CP, et al. Effect of fecal occult blood testing on mortality from colorectal cancer: a case-control study. Ann. Intern. Med., 118 (1993) 1–6.

    Article  PubMed  CAS  Google Scholar 

  12. Wahrendorf J, Robra B-P, Wiebelt H, et al. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany Eur. J. Cancer Prev., 2 (1993) 221–227.

    Article  PubMed  CAS  Google Scholar 

  13. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med., 343 (2000) 1603–1607.

    Article  PubMed  CAS  Google Scholar 

  14. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med., 326 (1992) 653–657.

    Article  PubMed  CAS  Google Scholar 

  15. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl. Cancer Inst., 84 (1992) 1572–1575.

    Article  PubMed  CAS  Google Scholar 

  16. Gohagen JK, Prorok PC, Kramer BS, et al. The prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute. Cancer, 75 (1995) 1869–1873.

    Article  Google Scholar 

  17. Atkin WS, Hart A, Edwards R, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut, 42 (1998) 560–565.

    Article  PubMed  CAS  Google Scholar 

  18. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 112 (1997) 594–642.

    Article  PubMed  CAS  Google Scholar 

  19. Rex DK, Johnson DA, Lieberman DA, et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am. J. Gastroenterol., 95 (2000) 868–877.

    PubMed  CAS  Google Scholar 

  20. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers and update 2001: testing for early lung cancer detection. CA: Cancer J. Clin., 51 (2001) 38–75.

    Article  CAS  Google Scholar 

  21. Lieberman DA, Weiss DG, Bond J, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N. Engl. J. Med., 343 (2000) 162–168.

    Article  PubMed  CAS  Google Scholar 

  22. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N. Engl. J. Med., 343 (2000) 169–174.

    Article  PubMed  CAS  Google Scholar 

  23. Fork FT. Double contrast enema and colonoscopy in polyp detection. Gut, 22 (1981) 971–977.

    Article  PubMed  CAS  Google Scholar 

  24. Hixson LJ, Fennerty MB, Sampliner RE, et al. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J. Natl. Cancer Inst., 82 (1990) 1769–1772.

    Article  PubMed  CAS  Google Scholar 

  25. Hixson LJ, Fennerty MB, Sampliner RE, et al. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest. Endoscopy, 37 (1991) 125–127.

    Article  CAS  Google Scholar 

  26. Steine S, Stordahl A, Lunde OC, et al. Double-contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: aspects of decision-making in general practice. Fam. Pract., 10 (1993) 288–291.

    Article  PubMed  CAS  Google Scholar 

  27. Jaramillo E and Slezak P. Comparison between double-contrast barium enema and colonoscopy to investigate lower gastrointestinal bleeding. Gastrointest. Radiol., 17 (1992) 81–83.

    Article  PubMed  CAS  Google Scholar 

  28. Jensen J, Kewenter J, Asztely M, et al. Double contrast barium enema and flexible rectosigmoidoscopy: a reliable diagnostic combination for detection of colorectal neoplasm. Br. J. Surg., 77 (1990) 270–272.

    Article  PubMed  CAS  Google Scholar 

  29. O’Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study: patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology, 98 (1990) 371–379.

    PubMed  Google Scholar 

  30. Shinya H and Wolff WI. Morphology, anatomic distribution and cancer potential of colonic polyps: an analysis of 7,000 polyps endoscopically removed. Ann. Surg., 190 (1979) 679–683.

    Article  PubMed  CAS  Google Scholar 

  31. Winawer SJ, Zauber AG, O’Brien MJ, et al. The National Polyp Study: design, methods, and characteristics of patients with newly diagnosed polyps. Cancer, 70 (1992) 1236–1245.

    Article  PubMed  CAS  Google Scholar 

  32. Rickert RR, Auerbach O, Garfinkel L, et al. Adenomatous lesions of the large bowel: an autopsy study. Cancer, 43 (1979) 1847–1857.

    Article  PubMed  CAS  Google Scholar 

  33. The National Polyp Study Workgroup, Winawer SJ, Zauber A, Diaz B. The National Polyp Study: temporal sequence of evolving colorectal cancer from the normal colon. Gastrointest. Endoscopy, 33 (1987) 167.

    Google Scholar 

  34. Muto T, Bussey HJR, and Morson BC. The evolution of cancer of the colon and rectum. Cancer, 36 (1975) 2251–2270.

    Article  PubMed  CAS  Google Scholar 

  35. Vasen HFA, Nagengast FM, and Meera Khan P. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet, 345 (1995) 1183–1184.

    Article  PubMed  CAS  Google Scholar 

  36. Markowitz AJ, Winawer SJ, Zauber AG, et al. Rapid appearance of colorectal cancer following negative colonoscopy in HNPCC. Gastroenterology, 116 (1999) A458 (abstract).

    Google Scholar 

  37. Burt RW and Petersen GM. Familial colorectal cancer: diagnosis and management. In Prevention and Early Detection of Colorectal Cancer. Young GP, Rozen P, Levin B (eds.), WB Saunders, London, 1996, pp. 171–194.

    Google Scholar 

  38. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N. Engl. J. Med., 334 (1996) 82–87.

    Article  PubMed  CAS  Google Scholar 

  39. Sachar DB. Cancer in inflammatory bowel disease. In Inflammatory Bowel Disease-Basic Research and Clinical Implications. Goebell H, Peskan BM, and Malchow H, (eds.), MTP Press, Boston, 1988, pp. 289–294.

    Google Scholar 

  40. Butt JH and Lennard-Jones JE. A practical approach to the cancer risk in inflammatory bowel disease. Med. Clin. North Am., 64 (1980) 1203–1220.

    PubMed  CAS  Google Scholar 

  41. Johnson W, McDermott F, Hughes E, et al. Carcinoma of the colon and rectum in inflammatory disease of the intestine. Surg. Gynecol. Obstet., 156 (1983) 193–197.

    PubMed  CAS  Google Scholar 

  42. Gyde SN, Prior P, Allan PN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut, 29 (1988) 206–217.

    Article  PubMed  CAS  Google Scholar 

  43. Katzka I, Brody R, Morris E, et al. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology, 85 (1983) 22–29.

    PubMed  CAS  Google Scholar 

  44. Lennard-Jones JE, Melville DM, Morson BC, et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut, 31 (1990) 800–806.

    Article  PubMed  CAS  Google Scholar 

  45. Brostrom O, Lofberg R, Nordenvall B, et al. The risk of colorectal cancer in ulcerative colitis: an epidemiologic study. Scand. J. Gastroenterol., 221 (1987) 1193–1199.

    Article  Google Scholar 

  46. Gilat T, Fireman Z, Grossman A, et al. Colorectal cancer in patients with ulcerative colitis: a population study in central Israel. Gastroenterology, 94 (1988) 870–877.

    PubMed  CAS  Google Scholar 

  47. Ransohoff DF. Colon cancer in ulcerative colitis. Gastroenterology, 94 (1988) 1089–1091.

    PubMed  CAS  Google Scholar 

  48. Lennard-Jones JE. Cancer risk in ulcerative colitis: surveillance of surgery. Br. J. Surg., 72 (1985) 584–586.

    Google Scholar 

  49. MacDougall IPM. Cancer risk in ulcerative colitis. Lancet, 2 (1964) 655–658.

    Article  PubMed  CAS  Google Scholar 

  50. Greenstein A, Sachar D, Smith H, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology, 77 (1979) 290–294.

    PubMed  CAS  Google Scholar 

  51. Waye JD. Screening for cancer in ulcerative colitis. Front. Gastrointest. Res., 10 (1986) 243–256.

    Google Scholar 

  52. Choi PM, Nugent FW, Schoetz DJ, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology, 105 (1993) 418–424.

    PubMed  CAS  Google Scholar 

  53. Greenstein AJ, Sachar DB, Smith H, et al. A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer, 48 (1981) 2742–2745.

    Article  PubMed  CAS  Google Scholar 

  54. Ekbom A, Helmick C, Zack M, et al. Increased risk of large bowel cancer in Crohn’s disease with colonic involvement. Lancet, 336 (1990) 357–359.

    Article  PubMed  CAS  Google Scholar 

  55. Sachar DB. Cancer in Crohn’s disease: dispelling the myths. Gut, 35 (1994) 1507–1508.

    Article  PubMed  CAS  Google Scholar 

  56. Moertel CG, Bargen JA, and Dockerty MB. Multiple carcinomas of the large intestine: a review of the literature and a study of 261 cases. Gastroenterology, 34 (1958) 85–98.

    PubMed  CAS  Google Scholar 

  57. Nava HR and Pagana TJ. Postoperative surveillance of colorectal carcinoma. Cancer, 49 (1982) 1043–1047.

    Article  PubMed  CAS  Google Scholar 

  58. Howard ML and Greene FL. The effect of preoperative endoscopy on recurrence and survival following surgery for colorectal carcinoma. Am. Surg., 56 (1990) 124–127.

    PubMed  CAS  Google Scholar 

  59. Brahme F, Ekelund G, Norden JG, et al. Metachronous colorectal polyps: comparison of development of colorectal polyps and carcinomas with and without history of polyps. Dis. Colon Rectum, 17 (1974) 166–171.

    Article  PubMed  CAS  Google Scholar 

  60. Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature, 328 (1987) 614–616.

    Article  PubMed  CAS  Google Scholar 

  61. Leppert M, Dobbs M, and Scambler P. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science, 238 (1987) 1411–1413.

    Article  PubMed  CAS  Google Scholar 

  62. Kinzler KW, Nilbert MC, Su Li-Kuo, et al. Identification of FAP locus genes from chromosome 5q21. Science, 253 (1991) 661–665.

    Article  PubMed  CAS  Google Scholar 

  63. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66 (1991) 589–600.

    Article  PubMed  CAS  Google Scholar 

  64. Jeghers H, McKusick VA, and Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits: a syndrome of diagnostic significance. N. Engl. J. Med., 241 (1949) 993–1005.

    Article  PubMed  CAS  Google Scholar 

  65. Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nature Genet., 18 (1998) 38–43.

    Article  PubMed  CAS  Google Scholar 

  66. Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature, 391 (1998) 184–187.

    Article  PubMed  CAS  Google Scholar 

  67. Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N. Engl. J. Med., 316 (1987) 1511–1514.

    Article  PubMed  CAS  Google Scholar 

  68. Spigelman AD, Murday V, and Phillips RKS. Cancer and the Peutz-Jeghers syndrome. Gut, 30 (1989) 1588–1590.

    Article  PubMed  CAS  Google Scholar 

  69. Watanabe A, Nagashima H, Motoi M, and Ogawa K. Familial juvenile polyposis of the stomach. Gastroenterology, 77 (1979) 148–151.

    PubMed  CAS  Google Scholar 

  70. Grotsky HW, Rickert RR, Smith WD, and Newsome JE Familial juvenile polyposis coli: a clinical and pathologic study of a large kindred. Gastroenterology, 82 (1982) 494–501.

    PubMed  CAS  Google Scholar 

  71. Sachatello CR, Pickren JW, and Grace JT Jr. Generalized juvenile gastrointestinal polyposis: a hereditary syndrome. Gastroenterology, 58 (1970) 699–708.

    PubMed  CAS  Google Scholar 

  72. Haggitt RC and Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am. J. Surg. Pathol., 10 (1986) 871–887.

    Article  PubMed  CAS  Google Scholar 

  73. Jarvinen H and Franssila KO. Familial juvenile polyposis coli: increased risk of colorectal cancer. Gut, 25 (1984) 792–800.

    Article  PubMed  CAS  Google Scholar 

  74. Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum, 34 (1991) 424–425.

    Article  PubMed  CAS  Google Scholar 

  75. Watson P and Lynch HT. Extracolonic cancer in Hereditary Nonpolyposis Colorectal Cancer. Cancer, 71 (1993) 677–685.

    Article  PubMed  CAS  Google Scholar 

  76. Vasen HFA, Watson P, Mecklin JP, et al. New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology, 116 (1999) 1453–1456.

    Article  PubMed  CAS  Google Scholar 

  77. Peltosmaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science, 260 (1992) 810–812.

    Article  Google Scholar 

  78. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog, MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75 (1993) 1027–1038.

    Article  PubMed  CAS  Google Scholar 

  79. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a muts homolog in hereditary nonpolyposis colorectal cancer. Cell, 75 (1993) 1215–1235.

    Article  PubMed  CAS  Google Scholar 

  80. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature, 368 (1994) 258–261.

    Article  PubMed  CAS  Google Scholar 

  81. Akiyama Y, Sato H, Yamada T, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res., 57 (1997) 3920–3923.

    PubMed  CAS  Google Scholar 

  82. Jarvinen HJ, Mecklin JP, and Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 108 (1995) 1405–1411.

    Article  PubMed  CAS  Google Scholar 

  83. Breite I, Markowitz A, Zauber A, et al. Colonoscopy screening of patients at high familial risk for colorectal cancer. Gastroenterology, 110 (1996) 495 (abstract).

    Google Scholar 

  84. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am. J. Gastroenterol., 95 (2000) 3053–3063.

    Article  PubMed  CAS  Google Scholar 

  85. Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N. Engl. J. Med., 328 (1993) 901–906.

    Article  PubMed  CAS  Google Scholar 

  86. Zauber AG, Winawer SJ, Bond JH, et al. Can surveillance intervals be lengthened following colonoscopic polypectomy? Gastroenterology, 112 (1997) A50 (abstract).

    Google Scholar 

  87. Zauber AG, Bond JH, and Winawer SJ. Surveillance of patients with colorectal adenomas or cancer. In Prevention and Early Detection of Colorectal Cancer. Young GP, Rozen P, and Levin B (eds.), WB Saunders, London, 1996, pp. 195–215.

    Google Scholar 

  88. Wagner JL, Tunis S, Brown M, et al. The cost effectiveness of colorectal cancer screening in average-risk adults. In Prevention and Early Detection of Colorectal Cancer. Young G and Levin B (eds.), WB Saunders, New York, 1996.

    Google Scholar 

  89. Eddy DM, Nugent FW, Eddy JF, et al. Screening for colorectal cancer in a high-risk population: results of a mathematical model. Gastroenterology, 92 (1987) 682–692.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Arnold J. Markowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gastrointestinal Oncology Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Leonard B. Saltz MD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Markowitz, A.J. (2002). Screening and Surveillance. In: Saltz, L.B. (eds) Colorectal Cancer. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-160-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-160-2_4

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9670-3

  • Online ISBN: 978-1-59259-160-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation